SITC Cancer Immunotherapy CONNECT


JITC Increases Impact Factor to 8.676
The Journal for ImmunoTherapy of Cancer (JITC), SITC’s open access, peer-reviewed online journal, has increased its impact factor to 8.676.

June is Cancer Immunotherapy Awareness Month™

Just announced for SITC 2019: The Novel Multi-Targeted Therapeutic Platforms Pre-Conference Program. Learn more about this great program and new SITC 2019 session, presentation and speaker information by clicking below.

Learn More

2019 SITC Logo Crop

SITC 2019 General Registration Now Open!
New session, presentation and speaker information now available!

New in JITC: Cancer Immune Responsiveness Workshop Manuscript
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop


Join SITC for two back-to-back immuno-oncology workshops
Sept. 4 - 6, 2019 | Houston, Texas



Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program

Cleveland, ohio on Sept. 5

chicago, Ill. on Sept. 28

boston, mass ON oct. 10

buffalo, N.Y. ON oct. 26

View More  Locations


NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity

A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.

Purchase Today


Winter School Enduring Materials Now Available to Public

Presentations from the 2019 Cancer Immunotherapy Winter School hosted Feb. 18–22, 2019, are now available to the general public.

Access Materials Today

2019 SITC Logo Crop

Submit an abstract for SITC 2019
Submit a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application by 5 p.m. PDT on Aug. 1, 2019.


2019 Lung Cancer and Immunotherapy Course 
A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now


Why I'm a SITC Member

Join Patrick Hwu, MD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


Inspire the Next Generation of Cancer Immunotherapy Leaders

Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.

Donate Today


Now Available:
SITC 2018 Enduring Materials



Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Posted in: Women in SITC

    Thank you Fabiana! Suggestions noted. For starters, if you have not yet done that, please apply to the WIN database (Women in Cancer Immunotherapy network) under the volunteer options. WIN is looking to create a database that can be used to better identify ...

  • Posted in: Women in SITC

    Hi Priscilla, it is a fact that women face additional challenges at advancing their careers compared to their male peers. I suggest we create more spots to increase female colleagues visibility at conferences (chairing sessions for instance) and perhaps ...

  • Posted in: Women in SITC

    Hello ladies I am excited to share that I am now a member of the SITC Early Career Scientist Committee! I would love to hear from you regarding any ideas/suggestions on how this committee can help women improve their careers in immunology. Priscila ------------------------------ ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More